A microbial supply chain for production of the anti-cancer drug vinblastine

Jie Zhang(Nanjing University of Chinese Medicine), Jay D. Keasling(QB3), Elena Carrasquer-Alvarez(University of Copenhagen), Vasil D’Ambrosio(Novo Nordisk Foundation), Emily Amor Stander(Université de Tours), Konrad Viehrig(Novo Nordisk Foundation), Christopher J. Petzold(Lawrence Berkeley National Laboratory), Saranya Nallapareddy(Novo Nordisk Foundation), Konstantina Giannakou(Novo Nordisk Foundation), Michael K. Jensen(Novo Nordisk Foundation), Sarah E. O’Connor(Max Planck Institute for Chemical Ecology), Lars Schrübbers(Technical University of Denmark), Leanne Jade G. Chan(Lawrence Berkeley National Laboratory), Khem B. Adhikari(Novo Nordisk Foundation), Vincent Courdavault(Université de Tours), Lærke Münter Lassen(Novo Nordisk Foundation), Edward E. K. Baidoo(Lawrence Berkeley National Laboratory), Suresh Sudarsan(Novo Nordisk Foundation), Olga Gudich(Novo Nordisk Foundation), Paulina Rubaszka(Novo Nordisk Foundation), Lea G. Hansen(Novo Nordisk Foundation), Marcos Laloux(Novo Nordisk Foundation), Beata Joanna Lehka(Novo Nordisk Foundation), Ahmad K. Haidar(Novo Nordisk Foundation), Tune Wulff(Novo Nordisk Foundation), Ling Chen(Novo Nordisk Foundation), Mette Kristensen(Novo Nordisk Foundation), Hanne Bjerre Christensen(Novo Nordisk Foundation), Marcus A. K. Jørgensen(Novo Nordisk Foundation), Dushica Arsovska(Novo Nordisk Foundation)
Nature
August 31, 2022
Cited by 449


Related Papers